tolnaftate 0.01 MG/MG Topical Powder [Hongo Killer Antifungal]

RxCUI
1101785
RxNorm name
tolnaftate 0.01 MG/MG Topical Powder [Hongo Killer Antifungal]
Term type
SBD
Status
Active
Updated
2026-06-15 07:03:07

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062011
Active start
062011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
tolnaftate0.01 MG / 1 MGtolnaftatetolnaftate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Powder317009

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
tolnaftate10637

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
58593-288-0758593-288Hongo Killer TolnaftateEfficient Laboratories IncM005

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M00558593-288Hongo Killer TolnaftateOTC MONOGRAPH DRUGEfficient Laboratories Inc

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
58593028804rxnav_ndcsyes
58593028807rxnav_ndcsyes

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
8c9c958a-2371-4ce5-948e-625c26cdaacbHongo Killer Antifungal 1 % Topical PowderSY18Drug Facts20251014
8c9c958a-2371-4ce5-948e-625c26cdaacbHongo Killer Antifungal 0.01 MG/MG Topical PowderSY18Drug Facts20251014
8c9c958a-2371-4ce5-948e-625c26cdaacbtolnaftate 0.01 MG/MG Topical Powder [Hongo Killer Antifungal]SBD18Drug Facts20251014
8c9c958a-2371-4ce5-948e-625c26cdaacbHongo Killer Antifungal 1 % Topical PowderPSN18Drug Facts20251014

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
8c9c958a-2371-4ce5-948e-625c26cdaacbDrug FactsEfficient Laboratories Inc20251014
8c9c958a-2371-4ce5-948e-625c26cdaacbDrug FactsEfficient Laboratories Inc20241014

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD01AEOther antifungals for topical useATC1-4tolnaftate
MEDRTD014047TolnaftateCHEMhas_ingredienttolnaftate
MEDRTD006967HypersensitivityDISEASEci_withtolnaftate
MEDRTD014009OnychomycosisDISEASEci_withtolnaftate
MEDRTD012536Scalp DermatosesDISEASEci_withtolnaftate
MEDRTD014008Tinea PedisDISEASEmay_treattolnaftate
MEDRTD014010Tinea VersicolorDISEASEmay_treattolnaftate
MEDRTN0000010265Squalene Monooxygenase InhibitorsMOAhas_moatolnaftate
MEDRTN0000008344Cellular Growth Phase ArrestPEhas_petolnaftate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESACTIVATED05/29/2024
ATTRIBUTESAVAILABLE_STRENGTH0.01 MG/MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBD
CODESRxCUI1101785
CODESSPL_SET_ID8c9c958a-2371-4ce5-948e-625c26cdaacb
NAMESPrescribable SynonymHongo Killer Antifungal 1 % Topical Powder
NAMESRXNAV_STRHongo Killer Antifungal 1 % Topical Powder
NAMESRxNorm Nametolnaftate 0.01 MG/MG Topical Powder [Hongo Killer Antifungal]
NAMESRxNorm SynonymHongo Killer Antifungal 0.01 MG/MG Topical Powder
NAMESRxNorm SynonymHongo Killer Antifungal 1 % Topical Powder
SOURCESSourceMetathesaurus FDA Structured Product Labels